IMGN logo

ImmunoGen (IMGN) Current Liabilities

Annual Current Liabilities

$121.86 M
+$20.91 M+20.72%

December 31, 2022


Summary


Performance

IMGN Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Quarterly Current Liabilities

$134.66 M
+$40.96 M+43.71%

September 30, 2023


Summary


Performance

IMGN Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIMGNbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

IMGN Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+20.7%+29.9%
3 y3 years+57.4%+34.9%
5 y5 years+118.5%+91.4%

IMGN Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-17.2%at high-37.5%
5 y5-year-0.4%-36.5%at high-42.5%
alltimeall time-0.4%-98.9%at high-99.0%

ImmunoGen Current Liabilities History

DateAnnualQuarterly
Sep 2023
-
$134.66 M(+43.7%)
Jun 2023
-
$93.70 M(-7.8%)
Mar 2023
-
$101.63 M(-16.6%)
Dec 2022
$121.86 M(+20.7%)
$121.86 M(+17.6%)
Sep 2022
-
$103.64 M(+19.0%)
Jun 2022
-
$87.07 M(+3.5%)
Mar 2022
-
$84.12 M(-16.7%)
Dec 2021
$100.94 M(-17.5%)
$100.94 M(-9.7%)
Sep 2021
-
$111.78 M(-7.1%)
Jun 2021
-
$120.32 M(-10.4%)
Mar 2021
-
$134.35 M(+9.8%)
Dec 2020
$122.32 M(+58.0%)
$122.32 M(+22.5%)
Sep 2020
-
$99.82 M(+9.8%)
Jun 2020
-
$90.88 M(+6.3%)
Mar 2020
-
$85.51 M(+10.5%)
Dec 2019
$77.41 M(+9.6%)
$77.41 M(-12.2%)
Sep 2019
-
$88.17 M(+18.2%)
Jun 2019
-
$74.62 M(+21.5%)
Mar 2019
-
$61.43 M(-13.1%)
Dec 2018
$70.66 M(+26.7%)
$70.66 M(+0.4%)
Sep 2018
-
$70.37 M(+11.1%)
Jun 2018
-
$63.35 M(-4.3%)
Mar 2018
-
$66.23 M(+18.8%)
Dec 2017
$55.77 M(-0.0%)
$55.77 M(-24.3%)
Sep 2017
-
$73.66 M(+9.4%)
Jun 2017
-
$67.35 M(+66.8%)
Mar 2017
-
$40.37 M(-28.2%)
Dec 2016
$55.78 M(-7.7%)
-
Sep 2016
-
$56.23 M(-7.0%)
Jun 2016
$60.44 M(+74.4%)
$60.44 M(+51.7%)
Mar 2016
-
$39.83 M(-9.3%)
Dec 2015
-
$43.90 M(+22.1%)
Sep 2015
-
$35.95 M(+3.7%)
Jun 2015
$34.65 M(+63.0%)
$34.65 M(+51.9%)
Mar 2015
-
$22.81 M(+16.1%)
Dec 2014
-
$19.64 M(-50.6%)
Sep 2014
-
$39.77 M(+87.1%)
Jun 2014
$21.25 M(+10.9%)
$21.25 M(+0.3%)
Mar 2014
-
$21.20 M(+20.2%)
Dec 2013
-
$17.63 M(+6.6%)
Sep 2013
-
$16.54 M(-13.7%)
Jun 2013
$19.17 M(+18.0%)
$19.17 M(+14.0%)
Mar 2013
-
$16.81 M(+14.9%)
Dec 2012
-
$14.63 M(-5.2%)
Sep 2012
-
$15.43 M(-5.1%)
Jun 2012
$16.25 M(+11.6%)
$16.25 M(+9.8%)
Mar 2012
-
$14.80 M(+27.3%)
Dec 2011
-
$11.62 M(-12.1%)
Sep 2011
-
$13.22 M(-9.2%)
Jun 2011
$14.57 M(+5.4%)
$14.57 M(+8.9%)
Mar 2011
-
$13.37 M(+24.5%)
Dec 2010
-
$10.74 M(+10.6%)
Sep 2010
-
$9.71 M(-29.8%)
Jun 2010
$13.82 M(+24.2%)
$13.82 M(+21.5%)
Mar 2010
-
$11.38 M(-1.7%)
Dec 2009
-
$11.57 M(+16.4%)
Sep 2009
-
$9.94 M(-10.7%)
Jun 2009
$11.13 M(+7.1%)
$11.13 M(-6.0%)
Mar 2009
-
$11.84 M(-8.6%)
Dec 2008
-
$12.95 M(+27.5%)
Sep 2008
-
$10.15 M(-2.2%)
Jun 2008
$10.39 M(-27.3%)
$10.39 M(-50.9%)
Mar 2008
-
$21.15 M(+58.2%)
Dec 2007
-
$13.36 M(+5.0%)
Sep 2007
-
$12.73 M(-10.9%)
Jun 2007
$14.29 M
$14.29 M(-0.4%)
Mar 2007
-
$14.35 M(+12.0%)
DateAnnualQuarterly
Dec 2006
-
$12.81 M(+3.6%)
Sep 2006
-
$12.36 M(+15.3%)
Jun 2006
$10.72 M(+16.2%)
$10.72 M(-14.8%)
Mar 2006
-
$12.58 M(+14.7%)
Dec 2005
-
$10.97 M(+16.2%)
Sep 2005
-
$9.44 M(+2.3%)
Jun 2005
$9.23 M(-18.2%)
$9.23 M(-18.6%)
Mar 2005
-
$11.33 M(+30.4%)
Dec 2004
-
$8.69 M(-16.3%)
Sep 2004
-
$10.38 M(-8.0%)
Jun 2004
$11.29 M(+94.2%)
$11.29 M(-21.1%)
Mar 2004
-
$14.31 M(+33.1%)
Dec 2003
-
$10.75 M(+24.4%)
Sep 2003
-
$8.64 M(+48.7%)
Jun 2003
$5.81 M(-10.7%)
$5.81 M(-12.7%)
Mar 2003
-
$6.66 M(-20.8%)
Dec 2002
-
$8.40 M(+17.3%)
Sep 2002
-
$7.16 M(+10.1%)
Jun 2002
$6.50 M(+21.3%)
$6.50 M(-7.1%)
Mar 2002
-
$7.00 M(-22.7%)
Dec 2001
-
$9.06 M(+68.5%)
Sep 2001
-
$5.37 M(+0.3%)
Jun 2001
$5.36 M(+117.2%)
$5.36 M(+54.9%)
Mar 2001
-
$3.46 M(+32.6%)
Dec 2000
-
$2.61 M(-33.0%)
Sep 2000
-
$3.89 M(+57.7%)
Jun 2000
$2.47 M(+37.1%)
$2.47 M(+58.3%)
Mar 2000
-
$1.56 M(-2.5%)
Dec 1999
-
$1.60 M(-5.9%)
Sep 1999
-
$1.70 M(-5.6%)
Jun 1999
$1.80 M(+20.0%)
$1.80 M(+28.6%)
Mar 1999
-
$1.40 M(+7.7%)
Dec 1998
-
$1.30 M(0.0%)
Sep 1998
-
$1.30 M(-13.3%)
Jun 1998
$1.50 M(-16.7%)
$1.50 M(+15.4%)
Mar 1998
-
$1.30 M(-23.5%)
Dec 1997
-
$1.70 M(+13.3%)
Sep 1997
-
$1.50 M(-16.7%)
Jun 1997
$1.80 M(-5.3%)
$1.80 M(-5.3%)
Mar 1997
-
$1.90 M(-17.4%)
Dec 1996
-
$2.30 M(+9.5%)
Sep 1996
-
$2.10 M(+10.5%)
Jun 1996
$1.90 M(-57.8%)
$1.90 M(-47.2%)
Mar 1996
-
$3.60 M(-2.7%)
Dec 1995
-
$3.70 M(-17.8%)
Sep 1995
-
$4.50 M(0.0%)
Jun 1995
$4.50 M(-8.2%)
$4.50 M(+9.8%)
Mar 1995
-
$4.10 M(+2.5%)
Sep 1994
-
$4.00 M(-18.4%)
Jun 1994
$4.90 M(+4.3%)
$4.90 M(-19.7%)
Mar 1994
-
$6.10 M(+64.9%)
Dec 1993
-
$3.70 M(+23.3%)
Sep 1993
-
$3.00 M(-36.2%)
Jun 1993
$4.70 M(+95.8%)
$4.70 M(+46.9%)
Mar 1993
-
$3.20 M(+39.1%)
Dec 1992
-
$2.30 M(+27.8%)
Sep 1992
-
$1.80 M(-25.0%)
Jun 1992
$2.40 M(+33.3%)
$2.40 M(+26.3%)
Mar 1992
-
$1.90 M(+11.8%)
Sep 1991
-
$1.70 M(-5.6%)
Jun 1991
$1.80 M(-18.2%)
$1.80 M(-10.0%)
Mar 1991
-
$2.00 M(+11.1%)
Dec 1990
-
$1.80 M(-5.3%)
Sep 1990
-
$1.90 M(-13.6%)
Jun 1990
$2.20 M(+69.2%)
$2.20 M(+22.2%)
Mar 1990
-
$1.80 M(+20.0%)
Sep 1989
-
$1.50 M(+15.4%)
Jun 1989
$1.30 M
$1.30 M

FAQ

  • What is ImmunoGen annual total current liabilities?
  • What is the all time high annual current liabilities for ImmunoGen?
  • What is ImmunoGen annual current liabilities year-on-year change?
  • What is ImmunoGen quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for ImmunoGen?
  • What is ImmunoGen quarterly current liabilities year-on-year change?

What is ImmunoGen annual total current liabilities?

The current annual current liabilities of IMGN is $121.86 M

What is the all time high annual current liabilities for ImmunoGen?

ImmunoGen all-time high annual total current liabilities is $122.32 M

What is ImmunoGen annual current liabilities year-on-year change?

Over the past year, IMGN annual total current liabilities has changed by +$20.91 M (+20.72%)

What is ImmunoGen quarterly total current liabilities?

The current quarterly current liabilities of IMGN is $134.66 M

What is the all time high quarterly current liabilities for ImmunoGen?

ImmunoGen all-time high quarterly total current liabilities is $134.66 M

What is ImmunoGen quarterly current liabilities year-on-year change?

Over the past year, IMGN quarterly total current liabilities has changed by +$31.02 M (+29.93%)